The risk of venous thromboembolism (VTE) in general surgery patients varies
from 10-50% depending on the type of surgery and underlying patient risk f
actors. Despite the availability of effective antithrombotic therapies, thr
omboprophylaxis is substantially underused in the general surgical field. T
he development of risk assessment models (RAMs) that can accurately and pro
spectively categorize patients according to their thromboembolic risk level
may lead to improved use of thromboprophylaxis. Several evidence-based RAM
s are now available that include general surgery in their range of clinical
categories, allowing patients to be stratified rapidly for thromboembolic
risk. Therapeutic recommendations are included in some cases, Tailoring ant
icoagulant therapy according to risk of VTE should maximize the clinical be
nefit and cost-effectiveness of prophylaxis, and minimize the risk of bleed
ing complications. Further studies are required to validate novel RAMs in c
linical practice, and to extend their scope to include patient groups with
particular needs, such as those undergoing neurosurgical procedures. (C) Li
ppincott & Williams & Wilkins.